Attrition in the therapeutic pipeline can typically result from a lack of translational efficacy between the pre-clinical phase and the clinic. Organoids offer much promise in drug screening and ...
Organoids and other 3D cell models are widely used in drug development because they are thought to be more realistic cell models and, therefore, have greater predictive potential. Cultivating these ...
Attrition in the therapeutic pipeline is often linked to the gap in translational efficacy between the pre-clinical phase and clinical outcomes. Organoids offer strong potential for improving disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results